Coralva Inversión SL, the company that runs the Instituto de Cirugía Plástica del Mediterráneo, a beneficiary of the EMPYME 2025 programme

Valencia, February 2026 — Coralva Inversión SL, the company that runs the Instituto de Cirugía Plástica del Mediterráneo, has been awarded a grant under the EMPYME 2025 programme by the Conselleria de Innovación, Industria, Comercio y Turismo de la Generalitat Valenciana (the Valencian Government’s department for innovation, industry, trade and tourism), worth €14,700. The programme supports the launch and consolidation of business projects with a strong innovative component in the Valencian Community.

The award is an institutional acknowledgement of the work done by the medical and technical team at the Instituto de Cirugía Plástica del Mediterráneo, and of its continuing commitment to clinical excellence, technological innovation and better clinical processes in plastic surgery and aesthetic medicine.

The aim of the EMPYME 2025 programme is to strengthen the competitiveness of Valencian business through projects that invest in better organisation, digitalisation, technological modernisation and sustainable value. Within that framework, Coralva Inversión SL is consolidating a strategy built on three pillars: innovation, clinical safety and continuous improvement.

The grant will allow the company to keep making progress in:

• Improving internal protocols and patient pathways.

• Improving quality control and quality assurance systems.

• Introducing technology that reinforces patient safety.

• Strengthening the centre’s organisational and technical structure.

This institutional backing consolidates the position of the Instituto de Cirugía Plástica del Mediterráneo as a specialist healthcare centre working to the highest standards of reliability, precision and safety, in a field where trust, transparency and medical rigour are decisive.

The management of Coralva Inversión SL welcomes the award, which supports the consolidation of the business and reinforces its commitment to continuous improvement, responsible healthcare and a positive impact on the economic and social life of the Valencian Community.

The company thereby reaffirms its intention to go on investing in innovation, professional talent and clinical excellence, contributing to a stronger healthcare business sector and to the standing of the Valencian Community as a benchmark in specialist, high-value services.